Palle Christophersen
Founder at SANA AB
Net worth: 157 694 $ as of 2024-03-30
Profile
Palle Christophersen is the founder of Saniona AB, which was founded in 2011.
He holds the title of Executive Vice President-Research at Saniona AB.
Dr. Christophersen is currently the Chief Scientific Officer at Saniona A.
Dr. Christophersen previously worked at NTG Nordic Transport Group A from 1991 to 2012, where he held the title of Vice President & Director-Vitro Pharmacology.
Dr. Christophersen obtained a doctorate degree from the University of Copenhagen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SANIONA AB
0.79% | 2022-12-30 | 874,571 ( 0.79% ) | 157 694 $ | 2024-03-30 |
Palle Christophersen active positions
| Companies | Position | Start |
|---|---|---|
| SANA AB | Founder | 2010-12-31 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Chief Tech/Sci/R&D Officer | - |
Former positions of Palle Christophersen
| Companies | Position | End |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 2011-12-31 |
Training of Palle Christophersen
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| SANA AB | Health Technology |
| Private companies | 1 |
|---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
- Stock Market
- Insiders
- Palle Christophersen
